Open AccessTo evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial
Author(s) -
Ekta Arora,
Vijay Khajuria,
Vishal R Tandon,
Atul Sharma,
Annil Mahajan,
Zahid Gillani,
Naiyma Choudhary
Publication year - 2015
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.148812
Subject(s) - placebo , overweight , medicine , waist , body mass index , randomized controlled trial , appetite , obesity , clinical trial , placebo controlled study , anthropometry , waist–hip ratio , surgery , double blind , pathology , alternative medicine
The aim of the following study is to evaluate the efficacy and safety of Caralluma fimbriata extract (CFE) in overweight and obese individuals in a prospective, randomized, placebo controlled trial.